For US Health Care Professionals Only
 
 
 

A consortium of health care providers from multiple disciplines collaborating to raise immunization rates
among older adolescents by establishing an immunization platform visit at 16 years of age.

View Resources
Image of two hands in handshake

Mission

To improve vaccination rates among adolescents by collaborating with stakeholders in the health care community to establish an immunization platform at age 16 years, elevating the importance of this visit on the immunization schedule.

Image of a light bulb

Vision

We envision a national immunization platform whereby all adolescents in the United States are properly immunized against vaccine-preventable diseases.

Image of 3 intersecting circles

16-Year-Old Immunization Platform Visit

In the 2017 schedule, the Advisory Committee on Immunization Practices (ACIP) instituted
a change by carving out an immunization visit specifically for adolescents 16 years of age to highlight the need for improving immunization rates across a number of older adolescent
immunizations.

Substantial Gaps Exist in Vaccination
Coverage Rates Among 13- to 17-Year-Olds

Immunization Rates in Adolescents 13-17 Years of Age1-3,a

Vaccine
Healthy People 2020
Goalsb
80%
Healthy People 2020
Influenza Goalc
70%
Tdapd
≥1 dose
89
MenACWYe
≥1 dose
85
MenACWY
≥2 dosesf
44
HPVg
≥1 dose, females
69
HPV
UTDh, females
53
HPV
≥1 dose, males
63
HPV
UTD, males
44
Influenzai
49
 
 
 
 
 
 
0
20
40
60
80
Estimated vaccination coverage (%)

a Data are from 2017, except where noted. Immunization rates are for adolescents aged 13-17 years. b Healthy People 2020 Goals are for 80% of adolescents to have received at least 1 Tdap dose, at least 1 MenACWY dose, and at least 3 HPV doses by age 13-15. No Healthy People 2020 Goal has been established for 2 doses of MenACWY or a single dose of HPV. c Healthy People 2020 Goal is for 70% of children 6 months to 17 years of age to have received an annual influenza vaccine. d Tdap = Tetanus, diphtheria, and acellular pertussis vaccine. e MenACWY = Quadrivalent meningococcal conjugate vaccine (serogroups A, C, W, and Y). f Second dose rate based on 17-year-olds. g HPV = Human papillomavirus vaccine. h UTD includes those with ≥3 doses, and those with 2 doses when the first HPV vaccine dose was initiated at age <15 years and at least 5 months minus 4 days elapsed between the first and second dose. i 2016-2017 influenza season.


Adapted from http://www.adolescentvaccination.org/resources/call-to-action-adolescent-vaccination-challenges.pdf on December 8, 2017, courtesy of the National Foundation for Infectious Diseases. Data updated for this website December, 2018.

References: 1. Centers for Disease Control and Prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2017. MMWR. 2018;67(33);909-917. 2. CDC. Flu vaccination coverage, United States, 2016-2017 influenza season. https://www.cdc.gov/flu/fluvaxview/coverage-1617. Accessed December 26, 2018. 3. HealthyPeople.gov. Immunization and infectious diseases. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed December 7, 2018.

Links to Organizations Working to Improve
Adolescent Immunization Rates